Zheng Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zheng Sun has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jie Lu
Department of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China
3 shared publications - Zhi Liu
Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China
3 shared publications - Ying-Ying Hu
Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China
2 shared publications - Feng Qin
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, College of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, P. R. China
1 shared publication - Fengqiu Zhang
Department of Periodontology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China
1 shared publication - Guang-Yan Huo
Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100748
Prognostic value of cardiac magnetic resonance pulmonary transit time and myocardial strain across different stages of ST-elevation myocardial infarction
- 14 April 2026
- Published by Elsevier in European Journal of Radiology Open
- Vol. 16, 100748
Open AccessPrognostic value of cardiac magnetic resonance pulmonary transit time and myocardial strain across different stages of ST-elevation myocardial infarction
- Open Access
- 30 May 2025
- Published by Elsevier in European Journal of Radiology Open
- Vol. 14, 100662
The role of resting-state perfusion CMR in the evaluation of microvascular obstruction in patients with acute myocardial infarction: A clinical perspective
- 30 May 2025
- Published by Elsevier in European Journal of Radiology Open
- Vol. 14, 100662
Open AccessThe role of resting-state perfusion CMR in the evaluation of microvascular obstruction in patients with acute myocardial infarction: A clinical perspective
- 16 February 2024
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
- Vol. 37 (3) , 1-13
A Motion-Aware DNN Model with Edge Focus Loss and Quality Control for Short-Axis Left Ventricle Segmentation of Cine MR Sequences
Accurate segmentation of the left ventricle myocardium is the key step of automatic assessment of cardiac function. However, the current methods mainly focus on the end-diastolic and the end-systolic frames in cine MR sequences and lack the attention to myocardial motion in the cardiac cycle. Additionally, due to the lack of fine segmentation tools, the simplified approach, excluding papillary muscles and trabeculae from myocardium, is applied in clinical practice. To solve these problems, we propose a motion-aware DNN model with edge focus loss and quality control in this paper. Specifically, the bidirectional ConvLSTM layer and a new motion attention layer are proposed to encode motion-aware feature maps, and an edge focus loss function is proposed to train the model to generate the fine segmentation results. Additionally, a quality control method is proposed to filter out the abnormal segmentations before subsequent analyses. Compared with state-of-the-art segmentation models on the public dataset and the in-house dataset, the proposed method has obtained high segmentation accuracy. On the 17-segment model, the proposed method has obtained the highest Pearson correlation coefficient at 14 of 17 segments, and the mean PCC of 85%. The experimental results highlight the segmentation accuracy of the proposed method as well as its availability to substitute for the manually annotated boundaries for the automatic assessment of cardiac function.
- 16 February 2024
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
- Vol. 37 (3) , 1-13
A Motion-Aware DNN Model with Edge Focus Loss and Quality Control for Short-Axis Left Ventricle Segmentation of Cine MR Sequences
Accurate segmentation of the left ventricle myocardium is the key step of automatic assessment of cardiac function. However, the current methods mainly focus on the end-diastolic and the end-systolic frames in cine MR sequences and lack the attention to myocardial motion in the cardiac cycle. Additionally, due to the lack of fine segmentation tools, the simplified approach, excluding papillary muscles and trabeculae from myocardium, is applied in clinical practice. To solve these problems, we propose a motion-aware DNN model with edge focus loss and quality control in this paper. Specifically, the bidirectional ConvLSTM layer and a new motion attention layer are proposed to encode motion-aware feature maps, and an edge focus loss function is proposed to train the model to generate the fine segmentation results. Additionally, a quality control method is proposed to filter out the abnormal segmentations before subsequent analyses. Compared with state-of-the-art segmentation models on the public dataset and the in-house dataset, the proposed method has obtained high segmentation accuracy. On the 17-segment model, the proposed method has obtained the highest Pearson correlation coefficient at 14 of 17 segments, and the mean PCC of 85%. The experimental results highlight the segmentation accuracy of the proposed method as well as its availability to substitute for the manually annotated boundaries for the automatic assessment of cardiac function.
- Open Access
- 25 June 2015
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (3) , 1841-1847
Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia
Peroxiredoxin 1 (Prx1) has a significant role in several malignant types of tumor. However, the role of Prx1 in oral leukoplakia (OLK) has remained to be elucidated. OLK is a common precancerous lesion of the oral mucosa that has a very high malignant transformation rate. The aim of the present study was to investigate the roles of Prx1, and its association with apoptosis signal-regulating kinase 1 (ASK1) and p38 in OLK. A total of 20 OLK samples and 10 normal oral mucosa samples were obtained from patients at the Beijing Stomatological Hospital (Beijing, China). The messenger RNA (mRNA) and protein expression levels of Prx1, ASK1 and p38 were determined by polymerase chain reaction and western blot analysis, respectively. Flow cytometry was used to detect cell apoptosis. The interaction between Prx1 and ASK1 was examined in H2O2-treated DOK cells by glutathione-S-transferase pull-down assays and by co-immunoprecipitation in vitro. Compared with those of the normal oral mucosa, the mRNA levels of Prx1, ASK1 and p38 were elevated in OLK tissues (P<0.05). The protein expression levels of Prx1, phosphorylated-ASK1 (p-ASK1) and p-p38 were also significantly enhanced in OLK tissues compared with those of the normal mucosa (P<0.05). In Prx1-knockdown DOK cells, ASK1 and p38 were activated, leading to enhanced levels of apoptosis in response to H2O2. No clear interaction between Prx1 and ASK1 was detected in H2O2-treated DOK cells. Prx1 was suggested to be involved in OLK pathogenesis by providing resistance against extracellular damages from oxidative stress via inhibition of the ASK1-induced apoptotic signaling pathway. Targeting Prx1 may provide a novel therapeutic strategy for the treatment of patients with OLK.
- 25 June 2015
- Published by Spandidos Publications in Oncology Letters
- Vol. 10 (3) , 1841-1847
Open AccessPeroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia
Peroxiredoxin 1 (Prx1) has a significant role in several malignant types of tumor. However, the role of Prx1 in oral leukoplakia (OLK) has remained to be elucidated. OLK is a common precancerous lesion of the oral mucosa that has a very high malignant transformation rate. The aim of the present study was to investigate the roles of Prx1, and its association with apoptosis signal-regulating kinase 1 (ASK1) and p38 in OLK. A total of 20 OLK samples and 10 normal oral mucosa samples were obtained from patients at the Beijing Stomatological Hospital (Beijing, China). The messenger RNA (mRNA) and protein expression levels of Prx1, ASK1 and p38 were determined by polymerase chain reaction and western blot analysis, respectively. Flow cytometry was used to detect cell apoptosis. The interaction between Prx1 and ASK1 was examined in H2O2-treated DOK cells by glutathione-S-transferase pull-down assays and by co-immunoprecipitation in vitro. Compared with those of the normal oral mucosa, the mRNA levels of Prx1, ASK1 and p38 were elevated in OLK tissues (P<0.05). The protein expression levels of Prx1, phosphorylated-ASK1 (p-ASK1) and p-p38 were also significantly enhanced in OLK tissues compared with those of the normal mucosa (P<0.05). In Prx1-knockdown DOK cells, ASK1 and p38 were activated, leading to enhanced levels of apoptosis in response to H2O2. No clear interaction between Prx1 and ASK1 was detected in H2O2-treated DOK cells. Prx1 was suggested to be involved in OLK pathogenesis by providing resistance against extracellular damages from oxidative stress via inhibition of the ASK1-induced apoptotic signaling pathway. Targeting Prx1 may provide a novel therapeutic strategy for the treatment of patients with OLK.
- 1 October 2012
- Published by Wolters Kluwer Health
- Vol. 47 (10) , 605-9
[Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells].
To evaluate the effects of sonicated extracts of Porphyromonas gingivalis (Pg) on receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) expression in human periodontal ligament cells (HPDLC) and the effect of Pg on bone resorption in periodontitis. HPDLC were exposed to 25, 50 mg/L sonicated extracts of Pg for 6 h, HPDLC without treatment served as control. The expression of RANKL-OPG mRNA and protein were examined by real time polymerase chain reaction and Western blotting. OPG protein in the supernatant was examined by enzyme linked immunosorbent assay (ELISA). The data were statistically analyzed by SPSS 13.0 and one-way analysis of variance (ANOVA). When HPDLC were exposed to sonicated extracts of Pg, the expression of RANKL mRNA and protein in 25 mg/L and 50 mg/L groups were higher than that of control group (P < 0.05), the expression of OPG mRNA in 50 mg/L group (0.087 ± 0.021) was lower than that of control group (0.240 ± 0.019) (P < 0.05), and OPG protein in 25 mg/L and 50 mg/L groups (0.813 ± 0.007, 0.398 ± 0.009) was lower than that of control group (1.131 ± 0.005) (P < 0.01). OPG protein expression in the supernatant was not significantly different between experimental group and control group. Sonicated extracts of Pg exposed to HPDLC can up-regulate RANKL expression, down-regulate OPG expression and influence bone metabolism.
- 1 October 2012
- Published by Wolters Kluwer Health
- Vol. 47 (10) , 605-9
[Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells].
To evaluate the effects of sonicated extracts of Porphyromonas gingivalis (Pg) on receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) expression in human periodontal ligament cells (HPDLC) and the effect of Pg on bone resorption in periodontitis. HPDLC were exposed to 25, 50 mg/L sonicated extracts of Pg for 6 h, HPDLC without treatment served as control. The expression of RANKL-OPG mRNA and protein were examined by real time polymerase chain reaction and Western blotting. OPG protein in the supernatant was examined by enzyme linked immunosorbent assay (ELISA). The data were statistically analyzed by SPSS 13.0 and one-way analysis of variance (ANOVA). When HPDLC were exposed to sonicated extracts of Pg, the expression of RANKL mRNA and protein in 25 mg/L and 50 mg/L groups were higher than that of control group (P < 0.05), the expression of OPG mRNA in 50 mg/L group (0.087 ± 0.021) was lower than that of control group (0.240 ± 0.019) (P < 0.05), and OPG protein in 25 mg/L and 50 mg/L groups (0.813 ± 0.007, 0.398 ± 0.009) was lower than that of control group (1.131 ± 0.005) (P < 0.01). OPG protein expression in the supernatant was not significantly different between experimental group and control group. Sonicated extracts of Pg exposed to HPDLC can up-regulate RANKL expression, down-regulate OPG expression and influence bone metabolism.